Sanofi Pasteur MSD's Andrea Rappagliosi Appointed President of Vaccines Europe

Lyon, France (ots/PRNewswire) -

Appointment marks new chapter in vaccine advocacy in Europe

Andrea Rappagliosi, Vice President of Market Access, Health Policy
& Medical Affairs at Sanofi Pasteur MSD has been appointed President
of Vaccines Europe as of 1st January 2013.

Vaccines Europe is the group representing vaccine manufacturers
within the European Federation of Pharmaceutical Industries and
Associations (EFPIA), the professional association of the European
pharmaceutical industry. Its members include established vaccine
companies such as Sanofi Pasteur MSD, AstraZeneca, Sanofi Pasteur,
Novartis, GlaxoSmithKline Biologicals, Pfizer, Crucell, Abbott,
Baxter and MSD.

Sanofi Pasteur MSD is one of the largest vaccines companies in
Europe and Andrea Rappagliosi's appointment highlights the calibre
and expertise of the new management team that has been brought in by
Jean Paul Kress, President of Sanofi Pasteur MSD, since he took over
the company in 2011.

"I am strongly supportive of Andrea's Presidency as it reflects
our commitment to maintain and strengthen healthcare excellence in
Europe for the benefit of people's health and wellbeing" said
Jean-Paul Kress, President of Sanofi Pasteur MSD. "Andrea's expertise
will boost Vaccines Europe's advocacy focus whilst highlighting
Sanofi Pasteur MSD's profile as a clear leader in vaccines in
Europe."

With twenty years of experience in the pharmaceutical industry and
a number of years within the Italian Institutions, Rappagliosi joined
Sanofi Pasteur MSD from GlaxoSmithKline in 2012 as Vice President of
Market Access, Health Policy & Medical Affairs.

About Sanofi Pasteur MSD

Sanofi Pasteur MSD is a joint venture between Sanofi Pasteur, the
vaccine division of Sanofi, and Merck, known as MSD outside the USA
and Canada. Combining innovation and expertise, Sanofi Pasteur MSD is
the only company in Europe dedicated exclusively to vaccines. Sanofi
Pasteur MSD is able to draw on the research expertise of Sanofi
Pasteur and Merck to focus on the development of new vaccines for
Europe to improve the acceptability, efficacy and tolerability of
vaccination.

About Vaccines Europe

Vaccines Europe (VE) is a specialized group within the European
Federation of Pharmaceutical Industries and Associations (EFPIA), the
professional association of the European pharmaceutical industry.
Formed in 1991 under the name European Vaccines Manufacturers (EVM),
the association set out to improve public health through immunization
and promoting R&D of innovative vaccines, Vaccines Europe member
companies are major manufacturers of vaccines worldwide, producing
the majority of vaccine doses in Europe. VE members are: Abbott
Biologicals, AstraZeneca, Baxter, Crucell, GlaxoSmithKline
Biologicals, MSD, Novartis Vaccines, Pfizer, Sanofi Pasteur and
Sanofi Pasteur MSD.

ots Originaltext: Sanofi Pasteur MSD GmbH
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information please contact: Caroline ASHE, Senior
Director External Communications Europe, Sanofi Pasteur MSD, Tel :
+33-4-37-28-4040, Mob: +33-6-33-46-1365, CAshe@spmsd.com